Close Menu

During his keynote address at the Genetics Society of America: Model Organisms to Human Biology meeting in Boston this week, National Institute of General Medical Sciences director Jeremy Berg spoke about advances in pharmacogenomics related to warfarin dosing, the recent NIH-wide changes to grant applications, and NIGMS genetics and genomics resources for those who study model organisms, "from A to Z — from Arabidopsis to zebrafish." Berg also spoke about how investigators who use model organisms in their work might be most likely to receive NIGMS funding for their work.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.